METTL3 and liver cancer: The results showed that overexpression of METTL3 and YTHDF1 promoted the ECAR levels and reduced the OCR levels in liver cancer cells, which could be reversed by knockdown of BFSP1 (Fig. 7b, and Fig. S3b).